Skandinaviska Enskilda Banken (SEB)
DVAX

Skandinaviska Enskilda Banken (SEB)’s Dynavax Technologies DVAX Stock Holding History

Skandinaviska Enskilda Banken (SEB)’s Portfolio DVAX Stock Details DVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-15,954
Closed -$245K – 329
2025
Q4 		$245K Buy
+15,954
New +$176K ﹤0.01% 689
2024
Q1 		– Sell
-23,800
Closed -$333K – 836
2023
Q4 		$333K Buy
+23,800
New +$331K ﹤0.01% 802

Other funds holding DVAX

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Skandinaviska Enskilda Banken (SEB)'s DVAX Position: Q1 2026 in Review

Skandinaviska Enskilda Banken (SEB) sold out of Dynavax Technologies (DVAX) in Q1 2026, closing a stake of 15,954 shares — an estimated $245K sold.

Skandinaviska Enskilda Banken (SEB) first reported a position in DVAX in Q4 2023 and held it in 2 quarters. The position peaked at $333K in Q4 2023. 1 fund tracked by Wall St. Rank holds DVAX as of Q1 2026.

  • Skandinaviska Enskilda Banken (SEB) reported no remaining Dynavax Technologies position as of Q1 2026 after selling out during the quarter.
  • Skandinaviska Enskilda Banken (SEB) sold 15,954 Dynavax Technologies shares in Q1 2026, an estimated $245K.
  • Skandinaviska Enskilda Banken (SEB) first reported a position in Dynavax Technologies in Q4 2023 and held it in 2 quarters.
  • Skandinaviska Enskilda Banken (SEB)'s Dynavax Technologies position peaked at $333K in Q4 2023.
  • 1 fund tracked by Wall St. Rank held Dynavax Technologies as of Q1 2026.

Based on Skandinaviska Enskilda Banken (SEB)'s 13F filing for Q1 2026, filed 15 May 2026.